This is in agreement with previous findings showing that the mesenchymal-like breast cancer stem cells are characterized as CD24−/CD44+, while the epithelial-like breast cancer stem cells express high levels of aldehyde dehydrogenase (ALDH) [16]. Here, CD44 is linked to breast cancer.